Publication | Closed Access

Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction

HypertensionCardiovascular DiseaseMedicineMyocardial InfarctionPhysiologyCardiovascular PharmacologyPharmacotherapySuperior CardioprotectionCardiovascular ToxicityPharmacologyCardiologyExperimental Myocardial Infarction